Formerly known as Felocell RESP-3 now will be labeled as Felocell FVR C Ch.
Vaccine

Feline Rhinotracheitis-Calici-Chlamydia Psittaci Vaccine, Modified Live Virus & Chlamydia

Description: Felocell FVR C Ch contains attenuated strains of feline rhinotracheitis virus, calicivirus, and Chlamydia psittaci propagated on established cell lines. Felocell FVR C Ch is packaged in freeze-dried form with inert gas in place of vacuum. Contains gentamicin as preservative.

Indications: Felocell FVR C Ch is for vaccination of healthy cats as an aid in preventing feline viral rhinotracheitis (FVR) caused by feline herpesvirus-1, feline respiratory disease caused by feline calicivirus (FCV), and feline chlamydiosis caused by C. psittaci.

Directions:
1. General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 1 mL intramuscularly or subcutaneously.
2. Primary Vaccination: Healthy cats 12 weeks of age or older should receive 2 doses administered 3-4 weeks apart. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.
3. Revaccination: Annual revaccination with a single dose is recommended.

Precaution(s): Store at 2°-7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Burn containers and all unused contents.

Caution(s): Vaccination of pregnant queens should be avoided.
The use of this product has been associated with fever, anorexia, and lethargy in 1% of vaccinated cats, often occurring in clusters in association with multiple concurrent vaccinations. The onset is typically delayed 7-21 days after vaccination. Symptoms may persist for 3-30 days with an average of 12 days after onset. Veterinary intervention may be required. When treatment is necessary, supportive care, steroids, and antibiotics have been utilized.
As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
For use in cats only.

Presentation: 25 x 1 dose vials.

This item is NON-RETURNABLE and NON-REFUNDABLE.